Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Flupenthixol And Melitracen

Flupenthixol and Melitracen: A Deep Dive Into the Controversial Combo

Introduction

Mental health disorders like depression and anxiety are among the leading causes of disability worldwide. The modern pharmacological landscape offers a variety of treatment options, from selective serotonin reuptake inhibitors (SSRIs) to atypical antipsychotics. Among the more unconventional combinations in psychiatry is the pairing of Flupenthixol and Melitracen, commonly sold under the brand name Deanxit.

While this combination has been popular in many countries, it remains controversial in others due to concerns over its efficacy, regulation, and lack of robust clinical trial data.

What is Flupenthixol?

Flupenthixol is a typical antipsychotic belonging to the thioxanthene class. It was first developed in the 1960s and has been used primarily in the treatment of schizophrenia, psychotic disorders, and in low doses for depressive and anxiety states.

Pharmacology of Flupenthixol

  • Acts primarily as a dopamine D1 and D2 receptor antagonist

  • In low doses, it has mild stimulant and anxiolytic properties

  • Can improve motivation, energy, and drive in depressed individuals

  • In higher doses, it exhibits antipsychotic effects, particularly beneficial for hallucinations and delusions

What is Melitracen?

Melitracen is a tricyclic antidepressant (TCA) structurally related to amitriptyline. It is less commonly known and not available as a standalone medication in many countries.

Pharmacology of Melitracen

  • Inhibits the reuptake of norepinephrine and serotonin, increasing their availability in the brain

  • Possesses antidepressant, anxiolytic, and sedative properties

  • Faster onset of action compared to some other TCAs

  • Lower incidence of side effects compared to traditional TCAs like amitriptyline

The Flupenthixol-Melitracen Combination: Why Are They Used Together?

This combination is commonly prescribed under the brand name Deanxit, and sometimes Franxit or Danxit, in various regions. It’s marketed as a fast-acting treatment for:

  • Depression

  • Anxiety disorders

  • Psychosomatic complaints (physical symptoms with no identifiable medical cause)

  • Psychogenic pain

  • Menopausal symptoms with mood disturbance

The rationale behind the combination lies in synergistic pharmacology:

  • Melitracen boosts mood through serotonin and norepinephrine elevation.

  • Flupenthixol enhances motivation, alertness, and reduces mental fatigue and anxiety.

Indications and Off-Label Uses

In clinical practice, this combination is prescribed for:

  • Mild to moderate depressive episodes

  • Generalized anxiety disorder (GAD)

  • Somatoform disorders

  • Neurasthenia

  • Chronic fatigue with depressive symptoms

  • Functional gastrointestinal or cardiovascular symptoms with psychological overlay

Its popularity often stems from perceived rapid onset (improvement within a few days) and the convenience of a single pill combining two drugs.

Dosage and Administration

A typical Deanxit tablet contains:

  • 0.5 mg Flupenthixol

  • 10 mg Melitracen

Standard Dosing:

  • 1–2 tablets daily, taken in the morning and early afternoon

  • Maximum recommended dose: 2–3 tablets per day

  • Not recommended for long-term use (usually 2–4 weeks)

Benefits of the Combination

1. Rapid Onset of Action

Patients often report improvement in mood and anxiety symptoms within 3–5 days, faster than many SSRIs or SNRIs.

2. Dual-Action Formula

Combines antidepressant effects with mild anxiolysis and stimulation, making it suitable for:

  • Apathetic depression

  • Depression with fatigue

  • Anxious-depressive states

3. Good Tolerability at Low Doses

Due to the small doses used, both drugs tend to have a lower side effect burden than if used individually at standard dosages.

4. Improvement in Psychosomatic Symptoms

Patients with chronic unexplained pain or fatigue, especially those with comorbid mood issues, may benefit from the combination’s physical and psychological effects.

Side Effects and Risks

Although generally well-tolerated, some patients may experience:

Common Side Effects:

  • Dry mouth

  • Constipation

  • Dizziness

  • Mild sedation

  • Nausea

Rare but Serious Risks:

  • Extrapyramidal symptoms (EPS): restlessness, tremor (from flupenthixol)

  • Weight gain

  • Orthostatic hypotension

  • Increased risk of serotonin syndrome when combined with other serotonergic drugs

  • Cardiovascular effects (e.g., palpitations, arrhythmias)

Dependency Concerns

Some users report psychological dependency, feeling anxious or unable to cope without the medication, despite the absence of physical withdrawal symptoms.

Controversies and Regulatory Challenges

1. Deanxit Banned in Several Countries

Despite its popularity in Asia, the Middle East, and parts of Europe, Deanxit is banned in the United States, United Kingdom, Australia, and several EU nations.

Reasons:

  • Lack of sufficient large-scale clinical trials

  • Absence of FDA or EMA approval

  • Regulatory standards regarding fixed-dose combinations

  • Concerns about long-term safety and over-prescription

2. Poor Documentation and Trial Data

Unlike SSRIs, the flupenthixol-melitracen combination lacks:

  • Head-to-head comparison studies with modern antidepressants

  • Longitudinal studies for long-term efficacy and safety

  • Published data in top-tier, peer-reviewed medical journals

3. Prescribed Without Clear Indication

In many countries, the combination is sold without prescription, or used for minor complaints like “tiredness” or “stress,” leading to overuse and misuse.

How Does It Compare to Modern Antidepressants?

Feature Flupenthixol-Melitracen SSRIs (e.g., Fluoxetine) SNRIs (e.g., Venlafaxine)
Onset Fast (3–5 days) Slower (1–3 weeks) Moderate (1–2 weeks)
Sedation Mild Variable Variable
Tolerability Generally good High Moderate
EPS risk Low at standard doses None None
Use in psychosis Flupenthixol useful Not effective Not effective

While modern antidepressants remain the gold standard for treating moderate to severe depression, this combination offers a valuable option for mild, psychosomatic, or anxious depression—especially where quick relief is desired.

Patient Testimonials and Experiences

Many patients describe:

  • Feeling “clearer,” “more energetic,” or “less foggy” within days

  • Improvement in unexplained physical symptoms (e.g., IBS, headaches)

  • Reduction in both depressive thoughts and social anxiety

  • Initial side effects like dry mouth or drowsiness that often resolve

However, a minority report:

  • Emotional blunting or flattening

  • Anxiety rebound when stopping suddenly

  • Difficulty tapering after long-term use

How to Use It Safely

If prescribed Flupenthixol and Melitracen:

✅ DO:

  • Take it in the morning to avoid sleep issues

  • Use it as a short-term treatment (2–4 weeks) unless directed otherwise

  • Combine with therapy or lifestyle changes

  • Monitor for side effects (especially movement-related ones)

❌ DON’T:

  • Use it as a first-line treatment without exploring other options

  • Take it without prescription or medical supervision

  • Mix with other antidepressants without guidance

  • Abruptly stop after long-term use

Withdrawal and Discontinuation

Stopping the medication suddenly may cause:

  • Anxiety rebound

  • Sleep disturbances

  • Mood dip

  • Dizziness or restlessness

A gradual taper under supervision is recommended if used longer than a few weeks.

Conclusion

The Flupenthixol-Melitracen combination (Deanxit) occupies a unique space in the psychopharmacological landscape. It offers rapid, dual-action relief for mild to moderate depression, psychosomatic complaints, and anxiety with fatigue. For many patients, especially those who do not tolerate SSRIs or need quick symptom relief, it can be a game-changer.

However, due to regulatory concerns, limited research, and potential for misuse, it should be prescribed cautiously, for short durations, and monitored closely. It is not a magic bullet, nor a replacement for comprehensive mental health care.

As with all psychiatric medications, individual response varies. When used wisely, with proper guidance and patient education, this controversial combination may continue to serve a meaningful role in global mental health treatment—especially where options are limited or fast intervention is needed.